Sanofi (SAN.PA)

Paris - Paris Delayed Price. Currency in EUR
68.86+0.75 (+1.10%)
At close: 11:35 AM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close68.11
Bid71.12 x 1000
Ask71.74 x 44000
Day's Range67.60 - 69.34
52wk Range25.29 - 69.34
1y Target EstN/A
Market Cap87.58B
P/E Ratio (ttm)21.41
Avg Vol (3m)9,870
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • TheStreet.com6 hours ago

    What to Look for When Sanofi (SNY) Reports Q3 Results

    Analysts are expecting to see a year-over-year decline in earnings and revenue when Sanofi (SNY) posts 2016 third-quarter results before Friday's market open.

  • Reuters19 hours ago

    Sanofi partners with Brazil to accelerate Zika vaccine work

    Sanofi has struck a collaboration deal with a leading Brazilian research institute to speed development of a Zika vaccine, consolidating the French drugmaker's position in the race to defeat the mosquito-borne virus. The deal with the Fiocruz public health centre follows a tie-up in July between Sanofi and a U.S. Army research institute, which gave the drugmaker access to one of the furthest advanced vaccines in development. Sanofi said on Thursday that all three research organisations would now work together to "increase the likelihood of successfully developing and licensing a safe and effective Zika vaccine as quickly as possible".

  • GlobeNewswire21 hours ago

    Sanofi Pasteur, Fiocruz, and WRAIR Agree to Collaborate on Zika Vaccine Research

    Sanofi Pasteur, Fiocruz, and WRAIR Agree to Collaborate on Zika Vaccine Research - The three research organizations have a history of flavivirus vaccine collaboration - Paris, France - October 27, 2016 ...